PRESS RELEASES
PUBLICATIONS & EVENTS
NEWS & PUBLICATIONS: PRESS RELEASES
November 10, 2009
Taligen Therapeutics Announces that TT30, a Novel Protein Targeting the Complement System, will be Highlighted in Two Presentations at the American Society of Hematology Meeting
December 5, 2008
Taligen Therapeutics Advances Corporate Growth Plan with Appointment of Jeffrey T. Walsh as Chief Business Officer
October 6, 2008
In Vivo
Data on Taligen Therapeutics’ Pipeline Candidates Presented at the XXII International Complement Workshop
September 25, 2008
Data from
In Vivo
Disease Models on Taligen Therapeutics’ Pipeline Candidates to be Presented at the XXII International Complement Workshop
July 23, 2008
Taligen Therapeutics Initiates Corporate Growth Plan
February 1, 2008
Taligen Therapeutics Secures Series B Financing
August 1, 2006
Taligen Therapeutics Announces Successful Achievement of Series A Milestone
[
back to top
]
